Global private equity and venture capital news and research

UK lower mid-market firm Elysian Capital backs Accelyon MBO

5 Aug 2013

UK lower mid-market private equity firm Elysian Capital has backed the management buyout of Accelyon, a company specialising in brachytherapy, an treatment option for early stage prostate cancer.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016